1. Scrip
  2. >>Therapy Areas
  3. >>Dermatological

Valeant On Upswing With Walgreens Deal

 
• By Lisa LaMotta

In its latest effort to turn around its image and recoup its sales after its distribution network went bust, Valeant Pharmaceuticals is teaming up with Walgreens to offer its dermatology and ophthalmology products at discounted rates.

Valeant announced Dec. 15 that it has inked a 20-year deal with the nation's largest retail pharmacy chain to distribute its products

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Dermatological

More from Therapy Areas

In Brief: Positive New Data For Aptose’s Triplet Therapy In 1L AML

 
• By Sushmita Panda

Aptose’s tuspetinib triplet shows early mutation-agnostic promise in new data from Phase I/II program for frontline acute myeloid leukemia.

Chinese Firms Build Obesity Clinical Pipeline But Face Wider Hurdles

 
• By Xu Hu

Despite the ability to initiate clinical trials quickly and having strong manufacturing capacity, Chinese companies are facing multiple challenges in the obesity space.

Aldeyra Plans To File Reproxalap Again With New Dry Eye Symptom Data

 
• By Joseph Haas

The biotech hopes a third time will be the charm after two FDA complete responses, with plans to position its eye drop as offering quicker onset of action.